NVOH Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
Quote as of Aug 26, 2026 19:28 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 26.37 | Day Range | 25.48 – 25.69 |
| 52-Week Range | 19.00 – 34.36 | Volume | 592 |
| Avg Volume | 2.20K | AUM | $4.3M (Aug 27, 2026) |
| Expense Ratio | 0.19% | Yield (TTM) | 6.66% |
| NAV | 24.36 | Premium/Discount | +4.59% indicative |
| Inception | Jan 02, 2025 | Holdings | — |
| Issuer | ADR hedged | Exchange | AMEX |
| Category | Developed Markets | Index Tracked | Not stated in source data |
| CUSIP | 74016W841 | ISIN | US74016W8414 |
| Management | Not stated in source data | ||
About this ETF
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -6.02% | +3.19% | +24.16% | -7.15% | -15.94% | — | — | — | -33.24% |
| Total return | -6.01% | +6.52% | +29.93% | -2.82% | -9.96% | — | — | — | -30.37% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 26, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.19% | Annual cost of a $10,000 investment | $19.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Jun 30, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 2 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Novo Nordisk A/S (B Shares) | NVO | 97.00% | 84.26K | $4.1M |
| 2 | Cash (US$) | — | 3.00% | 0 | $126.1K |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 6.66% | Paid (last 12 months) | $1.6960 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 16, 2026 | Last payment | $0.7670 (Jun 23, 2026) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 16, 2026 | Jun 16, 2026 | Jun 23, 2026 | $0.7670 |
| Mar 16, 2026 | Mar 16, 2026 | Mar 23, 2026 | $0.2750 |
| Dec 16, 2025 | Dec 16, 2025 | Dec 24, 2025 | $0.4880 |
| Sep 16, 2025 | Sep 16, 2025 | Sep 23, 2025 | $0.1660 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 44.30% / — | Sharpe 1Y / 3Y | -0.096 / — |
| Max drawdown 1Y / 3Y | -40.91% / — | Sortino 1Y | -0.129 |
| Beta vs S&P 500 (3Y) | 0.854 | Correlation vs S&P 500 (1Y) | 0.261 |
| Downside deviation 1Y | 32.87% | Risk-free rate used | 3.71% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 27, 2026. Formulas →
Liquidity
| Volume today | 592 | Average volume | 2.20K |
| AUM | $4.3M | Premium/Discount | +4.59% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $4.3M → $4.3M |
| 1 Week | -$88.2K | -2.07% | $4.3M → $4.3M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for NVOH
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.